Brainstorm Cell Therapeutics Inc.
BCLI· OTC
BCLIBrainstorm Cell Therapeutics Inc.
Filed Mar 29, 2017 · 10-K · 88 days after period end · 0001144204-17-017265
derived · Computed from the longer spans the company filed.
| Metric | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$624.00K | -$1.38M | -$2.73M | -$1.22M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Brainstorm Cell Therapeutics Inc. · CIK 1137883 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 29, 2017 · 88 d after period end
